-
AbCellera Biologics (NASDAQ:ABCL) Given "Hold" Rating at Benchmark
Source: Buzz FX / 03 Mar 2025 09:16:16 America/Chicago
AbCellera Biologics (NASDAQ:ABCL) Given "Hold" Rating at Benchmark Written by MarketBeat March 3, 2025 Share Link copied to clipboard. AbCellera Biologics ( NASDAQ:ABCL - Get Free Report ) 's stock had its "hold" rating reissued by analysts
Read more...